Literature DB >> 25318003

Arterial wall lymphangiogenesis is increased in the human iliac atherosclerotic arteries: involvement of CCR7 receptor.

Irmina Grzegorek1, Katarzyna Drozdz, Magdalena Chmielewska, Agnieszka Gomulkiewicz, Karolina Jablonska, Aleksandra Piotrowska, Maciej Karczewski, Dariusz Janczak, Marzena Podhorska-Okolow, Piotr Dziegiel, Andrzej Szuba.   

Abstract

Twenty-six iliac artery segments were divided in two groups: atherosclerotic (A) and nonatherosclerotic (NA). Expression of LYVE-1, VEGF-C, VEGF-D, and CCR7 receptor were studied with immunohistochemistry (IHC) and Western blot (WB). IHC was performed on 26 samples of iliac arteries obtained from deceased 19 organ donors. The samples were divided into an atherosclerotic group (A) [subjects with history of cardiovascular disease (hypertension, ischemic heart disease) or/and diabetes] (n=16), and a nonatherosclerotic group (NA) [subjects without any known cardiovascular diseases or cardiovascular risk factors] (n=10). WB was performed on 19 iliac artery segments obtained from two groups, based on clinical data: an atherosclerotic group (A) [patients with atherosclerosis, who underwent surgery for lower limb ischemia] (n=10), and a nonatherosclerotic group (NA) [deceased organ donors without cardiovascular diseases/risk factors (n=9)]. Expression of LYVE-1, VEGF-C, VEGF-D, and CCR-7 was increased in atherosclerotic arteries. Positive correlations between LYVE-1 and VEGF-C expression in the intima-media complex assessed by IHC: (r=0.54; p=0.005) and WB: (r=0.47; p=0.005) were found. Positive correlations between expression of CCR-7 and other markers were observed. Lymphangiogenesis is enhanced within the atherosclerotic arterial wall. Our results confirm lymphatic system activation with increased lymphangiogenesis and lymphocyte/macrophage trafficking in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25318003     DOI: 10.1089/lrb.2013.0048

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  6 in total

1.  Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2.

Authors:  Mahdi Taher; Shintaro Nakao; Souska Zandi; Mark I Melhorn; K C Hayes; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2016-03-22       Impact factor: 5.191

Review 2.  Arterial Lymphatics in Atherosclerosis: Old Questions, New Insights, and Remaining Challenges.

Authors:  Gábor Csányi; Bhupesh Singla
Journal:  J Clin Med       Date:  2019-04-11       Impact factor: 4.241

Review 3.  Blood⁻Brain Barrier, Lymphatic Clearance, and Recovery: Ariadne's Thread in Labyrinths of Hypotheses.

Authors:  Oxana Semyachkina-Glushkovskaya; Dmitry Postnov; Jürgen Kurths
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

4.  Serum sLYVE-1 is not associated with coronary disease but with renal dysfunction: a retrospective study.

Authors:  Daopeng Dai; Chunkai Huang; Jinwei Ni; Zhenbin Zhu; Hui Han; Jinzhou Zhu; Ruiyan Zhang
Journal:  Sci Rep       Date:  2019-07-25       Impact factor: 4.379

5.  Lymphatic vessels are present in human saccular intracranial aneurysms.

Authors:  Nora Huuska; Eliisa Netti; Satu Lehti; Petri T Kovanen; Mika Niemelä; Riikka Tulamo
Journal:  Acta Neuropathol Commun       Date:  2022-09-05       Impact factor: 7.578

6.  Role of R-spondin 2 in arterial lymphangiogenesis and atherosclerosis.

Authors:  Bhupesh Singla; Hui-Ping Lin; Alex Chen; WonMo Ahn; Pushpankur Ghoshal; Mary Cherian-Shaw; Joseph White; Brian K Stansfield; Gábor Csányi
Journal:  Cardiovasc Res       Date:  2021-05-25       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.